News & Updates
Filter by Specialty:
Long-term bimekizumab delivers durable efficacy in plaque psoriasis
Treatment with bimekizumab for 4 years results in satisfactory levels of clinical and health-related quality of life responses, reports a study. The majority of patients with moderate-to-severe plaque psoriasis achieve near-complete skin clearance, while nearly two-thirds have complete skin clearance.
Long-term bimekizumab delivers durable efficacy in plaque psoriasis
25 Sep 2025
Higher serum vitamin D levels may lower risks of death, CVD in psoriasis patients
Individuals with psoriasis may benefit from an increased level of serum 25-hydroxivitamin D (25[OH]D), which has shown an association with a reduced risk of overall mortality and cardiovascular disease (CVD) in a recent study.
Higher serum vitamin D levels may lower risks of death, CVD in psoriasis patients
24 Sep 2025
Cell harvesting device delivers repigmentation in stable vitiligo lesions
A cell harvesting device that prepares autologous skin cell suspension (ASCS) offers a simple yet accessible technique for melanocyte transplantation in patients with vitiligo, a study has shown.
Cell harvesting device delivers repigmentation in stable vitiligo lesions
27 Aug 2025
Secukinumab may reverse and prevent joint damage in psoriatic arthritis
Secukinumab may facilitate partial erosion repair and prevent enthesiophyte progression in patients with psoriatic arthritis (PsA), according to a phase IV randomized clinical trial (RCT).